These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1802818)

  • 1. Serum inhibin as an index of ovarian function in women undergoing pituitary suppression and ovarian stimulation in an in vitro fertilization program.
    Matson PL; Morris ID; Sun JG; Ibrahim ZH; Lieberman BA
    Horm Res; 1991; 35(5):173-7. PubMed ID: 1802818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins.
    Ibrahim ZH; Matson PL; Buck P; Critchlow JD; Newman MC; Horne G; Hughes S; Lieberman BA
    Hum Reprod; 1990 Apr; 5(3):258-62. PubMed ID: 2112554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
    Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibin levels in gonadotrophin stimulated in-vitro fertilization/gamete intra-fallopian transfer cycles.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Klinga K; Papp Z; Runnebaum B
    Hum Reprod; 1992 Oct; 7(9):1195-200. PubMed ID: 1478996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hormonal changes during combined buserelin/HMG treatment.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
    Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
    Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human preovulatory follicular fluid: inhibin and free steroids related to optimal follicular maturation in ovarian stimulation regimes and possible function in ovulation.
    Andersen CY; Westergaard LG; Sinosich MJ; Byskov AG
    Hum Reprod; 1992 Jul; 7(6):765-9. PubMed ID: 1500472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome.
    Hughes EG; Robertson DM; Handelsman DJ; Hayward S; Healy DL; de Kretser DM
    J Clin Endocrinol Metab; 1990 Feb; 70(2):358-64. PubMed ID: 2298853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immunoactive inhibin in the luteal phase and early gestation of women undergoing ovulation induction.
    McLachlan RI; Healy DL; Robertson DM; Burger HG; de Kretser DM
    Fertil Steril; 1987 Dec; 48(6):1001-5. PubMed ID: 3119369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?
    Wada I; Matson PL; Horne G; Buck P; Lieberman BA
    Hum Reprod; 1992 Sep; 7(8):1090-3. PubMed ID: 1400932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity and leptin levels on the secretion of estradiol, inhibin A and inhibin B during ovarian stimulation with gonadotropins.
    Urbancsek J; Fedorcsák P; Klinga K; Dévényi N; Papp Z; Rabe T; Strowitzki T
    Gynecol Endocrinol; 2002 Aug; 16(4):285-92. PubMed ID: 12396557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function?
    McLachlan RI; Robertson DM; Healy DL; de Kretser DM; Burger HG
    Lancet; 1986 May; 1(8492):1233-4. PubMed ID: 2872390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J; Hauzman EE; Murber A; Lagarde AR; Rabe T; Papp Z; Strowitzki T
    Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
    Bider D; Kokia E; Lipitz S; Blankstein J; Mashiach S; Serr DM; Ben-Rafael Z
    Gynecol Obstet Invest; 1990; 29(3):192-6. PubMed ID: 2113505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle.
    Tsonis CG; Messinis IE; Templeton AA; McNeilly AS; Baird DT
    J Clin Endocrinol Metab; 1988 May; 66(5):915-21. PubMed ID: 3129450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation.
    Smitz J; Bourgain C; Van Waesberghe L; Camus M; Devroey P; Van Steirteghem AC
    Hum Reprod; 1993 Jan; 8(1):40-5. PubMed ID: 8458924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
    Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
    Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Ascaso C; Vanrell JA
    Am J Obstet Gynecol; 1996 Nov; 175(5):1226-30. PubMed ID: 8942492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.